Hims & Hers Health, Inc.

US$26.00As of Sun 8 Nov 2026, 12:00 UTC
NYSE:HIMSHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 14.60%
Div yield —
ROE (32.03%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 2.50
PE TTM —
TSR TTM (42.81%)
Mkt cap US$6.066B
ROIC (10.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$28
7.63%
(87.55%)
Hold 1|6|1|6|12
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.48
0.50
0.52
0.54
4.95%
7.92%
12.88%
22.34%
Revenue$M
387.9
392.8
395.3
386.0
4.03%
7.59%
2.75%
0.42%
Peers (US$6.066B)
Cap (US$)
PE
5.434B
7.363x
5.968B
33.91x
Capital
TTM
5Y
10Y
Leveragex
1.112
0.983
0.774
EBIT/Intx
0.262
0.126
0.126
Own earn%
104.79
211.83
218.11
Sh yield%
28.44
40.23
42.64
Owners
Insiders/Inst%
14.36
56.77
Short interest%
4.06
SBC / revenue%
1.68
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
9–14
$1 testx
—
Incr. ROIC%
10